Skip to main content
BillionPhotos.com - stock.adobe.com

Assay Development

Metabolomic Service

We continuously expand our portfolio with new assays and adapt established assays to new sample matrices. Please contact Dr. Michael Witting (Michael.Witting@helmholtz-muenchen.de) in case you are interested in particular metabolites or samples matrices that are currently not covered by our existing portfolio.

Upcoming assays, that are currently under development:

  • Central Carbon Metabolism 
  • Total Fatty Acids (GC-MS)
  • Fatty acid-hydroxy fatty acids (FAHFAs)
  • Coenzyme Q9 & Q10 (HPLC-ECD)

We continuously expand our portfolio with new assays and adapt established assays to new sample matrices. Please contact Dr. Michael Witting (Michael.Witting@helmholtz-muenchen.de) in case you are interested in particular metabolites or samples matrices that are currently not covered by our existing portfolio.

Upcoming assays, that are currently under development:

  • Central Carbon Metabolism 
  • Total Fatty Acids (GC-MS)
  • Fatty acid-hydroxy fatty acids (FAHFAs)
  • Coenzyme Q9 & Q10 (HPLC-ECD)

Our Contact

Metabolomics Services Core Facility Metabolomics and Proteomics

Ingolstädter Landstraße 1 85764 Neuherberg, Building 25 and 34